Session 901: Intervention strategies

Cochair(s): H Vainio, RM Blaese
Date: 10 February 2004, Time: 08:30 - 11:00
Location: Room 1

Oral Presentations

Time	Number	Title / Authors / Affiliations
08:30	332	Stromal Cell Derived Factor-1 (SDF-1/CXCL12), CXCR4, CD26, and Hematopoietic Stem Cell Mobilization and Homing/Engraftment HE Broxmeyer PhD^a, W Clapp MD^a, G Bridger PhD^a, E Srour PhD^a, C Orschell PhD^a, G Hangoc DVM^a, S Cooper BS^a, K Christopherson PhD^b (a) Department of Microbiology and Immunology, and the Walther Oncology Center, Indiana University School of Medicine, Indianapolis IN, USA; (b) AnorMed Corp, Langley, British Columbia, Canada
08:55	333	T cell differentiation in allogeneic bone marrow chimeras K Onoe MD PhD^a, K Iwabuchi MD PhD^a, RA Good MD^b (a) Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan, (b) Department of Pediatrics, University of South Florida/All Children's Hospital, Tampa FL, USA
09:20	334	A revolutionary therapy for intractable diseases including malignant tumors S Ikehara MD First Department of Pathology, Transplantation Center, Regeneration Research Center for Intractable Diseases, Center for Cancer Therapy, Kansai Medical University
09:45	335	Immunological recovery following hematopoietic stem cells transplant for leukemia and lymphoma N Kapoor MD Division of Research Immunology/Bone Marrow TransplantationChildren’s Hospital Los Angeles, Keck School of Medicine at University of Southern California, Los Angeles, CA, United States
10:10	336	Lessons from the First Decade and a Half of Gene Therapy RM Blaese MD Fund for Inherited Disease Research Newtown, PA USA
10:35	337	Anti-cytokine (anti-IL6 receptor) therapy of chronic inflammations and hemopoietic malignancies T Kishimoto MD Osaka University Graduate School of Frontier Biosciences, Osaka, Japan